Literature DB >> 32482556

Complement Evasion by Lyme Disease Spirochetes.

Jon T Skare1, Brandon L Garcia2.   

Abstract

The complement system is an ancient arm of the innate immune system that plays important roles in pathogen recognition and elimination. Upon activation by microbes, complement opsonizes bacterial surfaces, recruits professional phagocytes, and causes bacteriolysis. Borreliella species are spirochetal bacteria that are transmitted to vertebrate hosts via infected Ixodes ticks and are the etiologic agents of Lyme disease. Pathogens that traffic in blood and other body fluids, like Borreliella, have evolved means to evade complement. Lyme disease spirochetes interfere with complement by producing a small arsenal of outer-surface lipoproteins that bind host complement components and manipulate their native activities. Here we review the current landscape of complement evasion by Lyme disease spirochetes and provide an update on recent discoveries.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lyme disease; complement evasion; pathogenesis

Mesh:

Substances:

Year:  2020        PMID: 32482556      PMCID: PMC7572514          DOI: 10.1016/j.tim.2020.05.004

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  94 in total

1.  Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals.

Authors:  John V McDowell; Kelley M Hovis; Hongming Zhang; Emily Tran; Justin Lankford; R T Marconi
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands.

Authors:  Utpal Pal; Xiaofeng Yang; Manchuan Chen; Linda K Bockenstedt; John F Anderson; Richard A Flavell; Michael V Norgard; Erol Fikrig
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins.

Authors:  Peter Kraiczy; Jens Hellwage; Christine Skerka; Heiko Becker; Michael Kirschfink; Markus M Simon; Volker Brade; Peter F Zipfel; Reinhard Wallich
Journal:  J Biol Chem       Date:  2003-11-07       Impact factor: 5.157

4.  Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates.

Authors:  Muriel C Schneider; Beverly E Prosser; Joseph J E Caesar; Elisabeth Kugelberg; Su Li; Qian Zhang; Sadik Quoraishi; Janet E Lovett; Janet E Deane; Robert B Sim; Pietro Roversi; Steven Johnson; Christoph M Tang; Susan M Lea
Journal:  Nature       Date:  2009-02-18       Impact factor: 49.962

5.  Microbes bind complement inhibitor factor H via a common site.

Authors:  T Meri; H Amdahl; M J Lehtinen; S Hyvärinen; J V McDowell; A Bhattacharjee; S Meri; R Marconi; A Goldman; T S Jokiranta
Journal:  PLoS Pathog       Date:  2013-04-18       Impact factor: 6.823

6.  Further structural insights into the binding of complement factor H by complement regulator-acquiring surface protein 1 (CspA) of Borrelia burgdorferi.

Authors:  Joseph J E Caesar; Reinhard Wallich; Peter Kraiczy; Peter F Zipfel; Susan M Lea
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-05-23

7.  Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity.

Authors:  Adam S Coleman; Xiuli Yang; Manish Kumar; Xinyue Zhang; Kamoltip Promnares; Deborah Shroder; Melisha R Kenedy; John F Anderson; Darrin R Akins; Utpal Pal
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

8.  BB0347, from the lyme disease spirochete Borrelia burgdorferi, is surface exposed and interacts with the CS1 heparin-binding domain of human fibronectin.

Authors:  Robert A Gaultney; Tammy Gonzalez; Angela M Floden; Catherine A Brissette
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

9.  Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex.

Authors:  Brandon L Garcia; Hui Zhi; Beau Wager; Magnus Höök; Jon T Skare
Journal:  PLoS Pathog       Date:  2016-01-25       Impact factor: 6.823

Review 10.  Functional anatomy of complement factor H.

Authors:  Elisavet Makou; Andrew P Herbert; Paul N Barlow
Journal:  Biochemistry       Date:  2013-05-31       Impact factor: 3.162

View more
  13 in total

1.  CspZ FH-Binding Sites as Epitopes Promote Antibody-Mediated Lyme Borreliae Clearance.

Authors:  Yi-Lin Chen; Ashley L Marcinkiewicz; Tristan A Nowak; Rakhi Tyagi Kundu; Zhuyun Liu; Ulrich Strych; Maria Elena Bottazzi; Wen-Hsiang Chen; Yi-Pin Lin
Journal:  Infect Immun       Date:  2022-07-05       Impact factor: 3.609

Review 2.  Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights.

Authors:  Wen-Hsiang Chen; Ulrich Strych; Maria Elena Bottazzi; Yi-Pin Lin
Journal:  Expert Rev Vaccines       Date:  2022-07-22       Impact factor: 5.683

3.  Utilizing Two Borrelia bavariensis Isolates Naturally Lacking the PFam54 Gene Array To Elucidate the Roles of PFam54-Encoded Proteins.

Authors:  Robert E Rollins; Janna Wülbern; Florian Röttgerding; Tristan A Nowak; Sabrina Hepner; Volker Fingerle; Gabriele Margos; Yi-Pin Lin; Peter Kraiczy; Noémie S Becker
Journal:  Appl Environ Microbiol       Date:  2022-01-05       Impact factor: 5.005

Review 4.  Investigation of the immune escape mechanism of Treponema pallidum.

Authors:  Yun Tang; Yingjie Zhou; Bisha He; Ting Cao; Xiangping Zhou; Lichang Ning; En Chen; Yumeng Li; Xiaoping Xie; Binfeng Peng; Yibao Hu; Shuangquan Liu
Journal:  Infection       Date:  2022-10-19       Impact factor: 7.455

Review 5.  Lyme Disease Pathogenesis.

Authors:  Jenifer Coburn; Brandon Garcia; Linden T Hu; Mollie W Jewett; Peter Kraiczy; Steven J Norris; Jon Skare
Journal:  Curr Issues Mol Biol       Date:  2020-12-23       Impact factor: 2.081

6.  Forty Years of Evidence on the Efficacy and Safety of Oral and Injectable Antibiotics for Treating Lyme Disease of Adults and Children: A Network Meta-Analysis.

Authors:  Jiaru Yang; Shiyuan Wen; Jing Kong; Peng Yue; Wenjing Cao; Xin Xu; Yu Zhang; Jingjing Chen; Meixiao Liu; Yuxin Fan; Lisha Luo; Taigui Chen; Lianbao Li; Bingxue Li; Yan Dong; Suyi Luo; Guozhong Zhou; Aihua Liu; Fukai Bao
Journal:  Microbiol Spectr       Date:  2021-11-10

Review 7.  The evolving story of Borrelia burgdorferi sensu lato transmission in Europe.

Authors:  Antje Steinbrink; Katharina Brugger; Gabriele Margos; Peter Kraiczy; Sven Klimpel
Journal:  Parasitol Res       Date:  2022-02-05       Impact factor: 2.289

8.  Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing.

Authors:  Michael J Pereira; Beau Wager; Ryan J Garrigues; Eva Gerlach; Joshua D Quinn; Alexander S Dowdell; Marcia S Osburne; Wolfram R Zückert; Peter Kraiczy; Brandon L Garcia; John M Leong
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-21       Impact factor: 12.779

Review 9.  Lyme arthritis: linking infection, inflammation and autoimmunity.

Authors:  Robert B Lochhead; Klemen Strle; Sheila L Arvikar; Janis J Weis; Allen C Steere
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 32.286

Review 10.  Molecular Mechanisms of Borrelia burgdorferi Phagocytosis and Intracellular Processing by Human Macrophages.

Authors:  Philipp Woitzik; Stefan Linder
Journal:  Biology (Basel)       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.